jilibet download apk latest version
jilibet download apk latest version
White supremacist Nick Fuentes is facing battery charges for allegedly macing a woman who confronted him on Nov. 10. In a report obtained Friday by multiple media outlets, Berwyn, Illinois police wrote that a passerby described seeing “a male push a female down the stairs, spray her with mace” and break her phone. Officers responding to the scene identified said male as Fuentes. They said the woman had been provoked by a viral social media post on Election Day, in which Fuentes celebrated an expected rollback of abortion rights by writing: “Your body, my choice. Forever.” “Nicholas then grabbed her phone and momentarily went inside his house before coming back out,” per the police report. “They both then waited for police to arrive. Marla related she did not want to sign complaints at this time.” The incident report, which was first obtained by The Smoking Gun, said Fuentes had been searched, fingerprinted and booked Nov. 27 on a misdemeanor battery charge. He was released but is set to appear in Cook County court on Dec. 19. Fuentes, a 26-year-old far-right influencer who has previously espoused his “love” for Nazi Germany’s Adolf Hitler, encouraged people to storm the U.S. Capitol in 2021 and dined with President-elect Donald Trump in 2022, is now selling “mugshot merch” on his website. Fuentes appeared to acknowledge the arrest on Friday on X , formerly Twitter, writing: “Free me n***a.” Fuentes’ address was leaked online after his anti-abortion post on the eve of Trump’s election, which eventually garnered more than 50,000 likes. He defended the post to police by arguing he simply “posted a political joke online,” per the report. Rose told Vice last month that she initially only intended to ask Fuentes if he had been harassed or received deliveries of diapers, since Rose said his critics on social media said they’d send him some. She said she only rang his doorbell when an onlooker encouraged her to. “I didn’t expect him to answer,” she told the outlet . “And then as I was saying hi, the spray immediately started. I was going to ask him, ‘Why do you feel comfortable saying the things that you say?’ And it was obvious he’s very scared, probably extremely paranoid.” “I’m 5-foot-1,” explained Rose. “He’s not a big man himself, but I’m 57, he’s 26.” Vice’s report also included a brief video clip of the scuffle. Fuentes told police he has been receiving death threats following his post on Election Day, and that he was in “fear for his life” when Rose appeared at his doorstep. Rose is reportedly planning to file a civil lawsuit against Fuentes over the incident. The “your body, my choice” line has taken on a life of its own. Many of Fuentes’ followers have seized on the phrase by using it to reply to women’s posts on various social media platforms, parents on TikTok have been sharing instances of boys harassing other children with it in real life. Related From Our PartnerUnderperforming Pacers welcome struggling Wizards
ZHONGSHAN, China , Nov. 23, 2024 /PRNewswire/ -- SUNLU was present at the Formnext 2024, the largest event for additive manufacturing held in Germany , where they unveiled the new product FilaDryer E2. SUNLU, the Chinese Tech Giant in the 3D printing industry, recently wrapped up a highly successful showcase at Formnext 2024, one of the largest events for additive manufacturing held in Frankfurt, Germany from November 19–22. SUNLU's booth (F29, Hall 11.1) hosted a large number of visitors eager to explore the company's latest innovations in 3D printing materials, equipment, and technology. A key highlight of SUNLU's exhibit was the new range of functional filaments, including PA6-CF, PA12-CF, PC-ABS, and PETG-CF. The filaments provide enhanced strength, durability, and temperature resistance, catering to more demanding applications in both industrial and personal use. Visitors saw firsthand how these materials impact the quality, resilience and overall performance of 3D-printed parts. The debut of the SUNLU FilaDryer E2 also attracted significant interest for its powerful features, notably its maximum drying temperature of 110°C, which allows for the fast drying of functional filaments and annealing printed parts to improve their strength and durability. The FilaDryer E2 will be available for preorder on January 8, 2025 , on our official website . Visitors expressed great anticipation, after seeing the upgrades that set the FilaDryer E2 apart. Jack Jiang , the founder of SUNLU, said: "This opportunity allowed us to position and showcase SUNLU as one of the key global players in the 3D Industry." Formnext 2024 was a valuable opportunity for SUNLU to connect with peers, partners, and customers worldwide. The team exchanged ideas with industry professionals and distributors, where the company had the opportunity to interview James Rooke from "Honey Badger Print and Paint" and talk about the new SUNLU's Filament Connector FC01 and it's perks to make the most out of leftover materials, while enabling multi-color prints. As the exhibition comes to an end, the SUNLU team extends heartfelt thanks to everyone who visited the booth and made the event memorable, and the company looks forward to meeting up again next year for groundbreaking solutions and meaningful partnerships within the additive manufacturing community. About SUNLU Founded in 2013, SUNLU is a leading 3D printing materials company specializing in R&D, manufacturing, and sales. With facilities in China and Vietnam , we operate 150+ automated production lines and employ over 900 staff. Our certified products serve customers across Europe , America, and Southeast Asia. SUNLU has led 30+ research projects, secured 400+ patents, and introduced innovations like "Neat Winding" filament, 3D printing drying boxes, and the ±0.02mm FDM filament tolerance standard, enhancing precision and user experience. Guided by our mission, "Simply Your Creation," we empower creators worldwide with reliable 3D printing materials. For more information, please visit https://www.sunlu.com . Media Contact: Branding@sunlu.com Sales@sunlu.com Stay Updated: If you're interested in the FilaDryer E2, sign up here to receive exclusive preorder information and updates directly in your inbox. View original content to download multimedia: https://www.prnewswire.com/news-releases/sunlu-formnext-2024-event-highlights-from-functional-filaments-to-filadryer-e2-302314231.html SOURCE SUNLU
(The Center Square) – The question before the U.S. Supreme Court on Wednesday was whether a Tennessee law banning gender dysphoria treatment for minors is unconstitutional. Twenty-three other states have similar bans, but the Tennessee case is the first one to have made it to the nation's highest court. Behind the legal questions debated are medical questions that are in dispute. A transgender girl identified as "L Williams" is at the center of the case brought by the American Civil Liberties Union and later supported by the Biden administration. In an article posted on the ACLU's website, L said she was emotionally distressed as she began puberty. “You're at a point where not only are you going through puberty, but you're also going through nightmare puberty,” L said. “I mean, obviously, nobody's 100% comfortable with [the changes,] but you're immensely uncomfortable with them.” L's parents sought puberty and hormone blockers in another state when Tennessee lawmakers passed its ban in 2023. They were on the steps of the U.S. Supreme Court when the case was argued. Also on the steps was Dr. Jared Ross, a member of Do No Harm, a group of medical professionals who say their mission is to keep identity politics out of medical education, research, and clinical practice. Ross has a story, too, about a blue-haired girl who came into an emergency room one night. She described herself as "gender-confused," Ross said in an interview with The Center Square. "She was cutting herself with a razor blade because voices were telling her to," Ross said. "Can you imagine if I had affirmed these voices, affirming what she was hearing? That would have been malpractice, that would have been criminal. I didn't affirm those voices. I also didn't affirm her gender confusion." Do No Harm filed an amicus brief challenging the medical evidence presented by the ACLU and the Biden administration. It points to a study called the "Cass Review," a multi-year project from the United Kingdom that said studies of the use of puberty blockers and cross-sex hormones were uncontrolled observational studies subject to bias." The ACLU says it also has medical evidence on its side. The American Medical Association and the American College of Pediatrics are among the groups that support gender dysphoria treatment for minors. At least one medical organization is taking a second look at the treatments. The American Society of Plastic Surgeons said in April that it is reviewing the practice. "ASPS currently understands that there is considerable uncertainty as to the long-term efficacy for the use of chest and genital surgical interventions for the treatment of adolescents with gender dysphoria, and the existing evidence base is viewed as low quality/low certainty. This patient population requires specific considerations," the organization said in a statement. Doctors who don't support treatments for gender dysphoria for minors are accused of discrimination and not caring about the patients. But that's not the case, Ross said. "The other side often plays this as we're neglecting these kids or we're minimizing their suffering that they're going through," Ross said. "I don't doubt that they're suffering. They're suffering tremendously. They need love and compassion and good evidence-based mental health care." Until the Supreme Court rules in 2025, the Tennessee law and others like it will stay on the books.
None
'Trust and reserve judgement' on rebrand, says JaguarNEW YORK, Dec. 22, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against PACS Group, Inc. (NYSE: PACS) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in PACS, you are encouraged to obtain additional information by visiting : https://www.bfalaw.com/cases-investigations/pacs-group-inc . Investors have until January 13, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 11 and 15 of the Securities Act of 1933 and Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in PACS securities. The case is pending in the U.S. District Court for the Southern District of New York and is captioned Manchin v. PACS Group, Inc. , et al. , No. 24-cv-08636. What is the PACS Lawsuit About? The Complaint alleges that PACS is one of the largest operators of skilled nursing facilities in the United States. As alleged, PACS repeatedly represented to shareholders that it possesses a winning “turnaround” strategy to make its nursing facilities profitable. However, in truth, it is alleged that PACS’s turnaround was driven by illicitly accessing Medicare benefits for thousands of patients. On November 4, 2024, prominent investment research firm Hindenburg Research published a report titled: “PACS Group: How to Become A Billionaire In The Skilled Nursing Industry By Systematically Scamming Taxpayers.” After a 5-month investigation that included interviews with 18 former PACS employees, competitors, and an analysis of more than 900 PACS facility cost reports, Hindenburg alleged that “PACS abused a COVID-era waiver, inappropriately accessing skilled care Medicare benefits for thousands of patients across its national portfolio of facilities.” Hindenburg further estimated that “the scheme drove more than 100% of PACS’ operating and net income from 2020 – 2023, enabling PACS to IPO in early 2024 with the illusion of legitimate growth and profitability.” On November 6, 2024, PACS then announced that it was postponing its Q3 earnings and that it had “received civil investigative demands from the federal government regarding the Company’s reimbursement and referral practices that may or may not be related to this week’s third-party report.” The news caused a significant decline in the price of PACS stock. On November 4, 2024, the price of the company’s stock fell 27.8%, from a closing price of $42.94 per share on November 1, 2024, to $31.01 per share on November 4, 2024. On November 6, 2024, the price of the company’s stock fell 38.8%, from a closing price of $29.54 per share on November 5, 2024, to $18.09 per share on November 6, 2024. Click here if you Suffered Losses: https://www.bfalaw.com/cases-investigations/pacs-group-inc . What Can You Do? If you invested in PACS you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses. Submit your information by visiting: https://www.bfalaw.com/cases-investigations/pacs-group-inc Or contact: Ross Shikowitz ross@bfalaw.com 212-789-3619 Why Bleichmar Fonti & Auld LLP? Bleichmar Fonti & Auld LLP is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It was named among the Top 5 plaintiff law firms by ISS SCAS in 2023 and its attorneys have been named Titans of the Plaintiffs’ Bar by Law360 and SuperLawyers by Thompson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors (pending court approval), as well as $420 million from Teva Pharmaceutical Ind. Ltd. For more information about BFA and its attorneys, please visit https://www.bfalaw.com . https://www.bfalaw.com/cases-investigations/pacs-group-inc Attorney advertising. Past results do not guarantee future outcomes.
